Economic burden of myasthenia gravis in China: a nationwide registry-based study
Population with MG in China reported heavy economic burdens related to medication. Disease severity is a major driving factor of both direct and indirect costs. Targeted policies are needed to alleviate the financial burden of MG on patients and society at large.
Authors
- Jiazhou Yu (ORCID: https://orcid.org/0000-0002-9249-2721)
- Shanquan Chen (ORCID: https://orcid.org/0000-0002-4724-4892)
- Dong Dong (ORCID: https://orcid.org/0000-0001-9784-6472)
- Huanyu Zhang (ORCID: https://orcid.org/0000-0001-6480-2510)
Institutions
- Sun Yat-sen University (CN)
- Chinese University of Hong Kong (HK)
- London School of Hygiene & Tropical Medicine (GB)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Hong Kong Jockey Club (HK)
- Chinese University of Hong Kong, Shenzhen (CN)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1080/03007995.2025.2475075
- Citations
- 3
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 4.17